alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 89, Number 15 (Tuesday, January 23, 2024)]
[Notices]
[Page 4274]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-01256]


========================================================================
Notices
                                                Federal Register
________________________________________________________________________

This section of the FEDERAL REGISTER contains documents other than rules 
or proposed rules that are applicable to the public. Notices of hearings 
and investigations, committee meetings, agency decisions and rulings, 
delegations of authority, filing of petitions and applications and agency 
statements of organization and functions are examples of documents 
appearing in this section.

========================================================================


Federal Register / Vol. 89, No. 15 / Tuesday, January 23, 2024 / 
Notices

[[Page 4274]]



AMERICAN BATTLE MONUMENTS COMMISSION


Performance Review Board Appointments

AGENCY: American Battle Monuments Commission.

ACTION: Notice of performance review board appointments.

-----------------------------------------------------------------------

SUMMARY: This notice provides the names of individuals who have been 
appointed to serve as members of the American Battle Monuments 
Commission Performance Review Board. The publication of these 
appointments is required by section 405(a) of the Civil Service Reform 
Act of 1978.

DATES: These appointments are effective as of 01 October 2023.

FOR FURTHER INFORMATION CONTACT: Jamilyn Smyser, Chief of Human 
Resources and Administration, American Battle Monuments Commission, 
Courthouse Plaza II, Suite 500, 2300 Clarendon Boulevard, Arlington, 
Virginia 22201. Telephone number: (703) 584-1552

American Battle Monument Commission SES Performance Review Board--2022/
2023

Dr. Erin Mahan, Chief Historian, Office of the Secretary of Defense
Mr. Mark Averill, Deputy Administrative Assistant to the Secretary of 
the Army
Michael Conley, Chief of Staff, American Battle Monuments Commission

Kelly Dove,
Chief, Human Resources and Administration.
[FR Doc. 2024-01256 Filed 1-22-24; 8:45 am]
BILLING CODE 6120-01-P
#### UNITED STATES of America, Appellee, v. Thomas R. HUNTER, Appellant.

No. 02-2970.

United States Court of Appeals, Eighth Circuit.

Submitted Feb. 6, 2003.

Decided Feb. 11, 2003.

Before BOWMAN, WOLLMAN, and BYE, Circuit Judges.

[UNPUBLISHED]

PER CURIAM.

Thomas Hunter pleaded guilty to knowingly possessing a firearm transported in interstate commerce after he had been convicted of a felony, in violation of 18 U.S.C. §§ 922(g)(1) and 924(a)(2). His sentence was enhanced under the Armed *796Career Criminal Act, 18 U.S.C. § 924(e), based on three prior violent felony convictions, and the district court1 sentenced him to 180 months of imprisonment and 5 years of supervised release. On appeal, counsel has moved to withdraw under *Anders v. California,*386 U.S. 738, 87 S.Ct. 1396, 18 L.Ed.2d 493 (1967), and has filed a brief raising the issue whether two of Hunter’s prior convictions — a 1984 burglary conviction and a 1974 robbery conviction — qualified as violent felonies when he committed the underlying crimes. Hunter has filed a pro se supplemental brief, in which he joins counsel in making this argument, and also argues that the burglary conviction did not present a serious risk of physical injury, the robbery conviction should not have been used as a predicate offense because his civil rights had been restored, and the firearms underlying the instant conviction did not travel in interstate commerce.

We find that Hunter is foreclosed from challenging the length of his sentence. He stipulated in his plea agreement that the proper sentence was 180 months under section 924(e) and the Guidelines; he did not file written objections to the presen-tence report, which recommended a sentence of 180 months; and his counsel conceded at sentencing that the court was limited to imposing a 180-month sentence. *See United States v. Nguyen,*46 F.3d 781, 783 (8th Cir.1995) (defendant who explicitly and voluntarily exposes himself to specific sentence may not challenge that punishment on appeal). As to the challenge to his conviction, the felon-in possession indictment to which Hunter pleaded guilty stated that all of the firearms had been transported in interstate commerce.

Following our independent review, *see Penson v. Ohio,*488 U.S. 75, 109 S.Ct. 346, 102 L.Ed.2d 300 (1988), we find no nonfrivolous issues. Accordingly, we affirm the judgment of the district court, and we grant counsel’s motion to withdraw.

1

. The Honorable Scott O. Wright, United States District Judge for the Western District of Missouri.
Exhibit 23.1
  CONSENT
    OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
  (Form S-8 No. 333-147925) (Form 10-K)
  /s/
    Ernst & Young LLP
IN THE SUPREME COURT OF THE STATE OF MONTANA No. DA 22

- 054 3 STATE OF MONTANA,

Plaintiff and Appellee, v. JUSTIN GUY ZENO SHAWN WOLF MASON ,

Defendant and Appellant.

**GRANT** Pursuant to authority granted under Mont. R. App. P. 26(1), the Appellant is given an extension of time until December 30 , 2022, to prepare, file, and serve the Appellant’s opening brief.

Electronically signed by: Bowen Greenwood Clerk of the Supreme Court November 21 2022

11/21/2022

Case Number: DA 22-0543
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Human Genome Research Institute Initial Review Group; Genome Research Study Section.                    

*Date:*                         March 7, 2024.                    

*Time:*                         11:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge, Drive Bethesda, MD 20817.                    

*Contact Person:*                         Lori Bonnycastle, Ph.D., Scientific Review Officer, 50 South Drive, National Human Genome Research Institute, National Institute of Health, Building 50, Room 5314, Bethesda, MD 20892, 301-594-9206,                         *lbonnyca@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS)

Dated: January 22, 2024.

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2024-01522 Filed 1-25-24; 8:45 am]

BILLING CODE 4140-01-P
[Federal Register Volume 89, Number 18 (Friday, January 26, 2024)]
[Notices]
[Page 5235]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-01602]


=======================================================================
-----------------------------------------------------------------------

FEDERAL RESERVE SYSTEM


Change in Bank Control Notices; Acquisitions of Shares of a Bank 
or Bank Holding Company

    The notificants listed below have applied under the Change in Bank 
Control Act (Act) (12 U.S.C. 1817(j)) and Sec.  225.41 of the Board's 
Regulation Y (12 CFR 225.41) to acquire shares of a bank or bank 
holding company. The factors that are considered in acting on the 
applications are set forth in paragraph 7 of the Act (12 U.S.C. 
1817(j)(7)).
    The public portions of the applications listed below, as well as 
other related filings required by the Board, if any, are available for 
immediate inspection at the Federal Reserve Bank(s) indicated below and 
at the offices of the Board of Governors. This information may also be 
obtained on an expedited basis, upon request, by contacting the 
appropriate Federal Reserve Bank and from the Board's Freedom of 
Information Office at https://www.federalreserve.gov/foia/request.htm. 
Interested persons may express their views in writing on the standards 
enumerated in paragraph 7 of the Act.
    Comments regarding each of these applications must be received at 
the Reserve Bank indicated or the offices of the Board of Governors, 
Ann E. Misback, Secretary of the Board, 20th Street and Constitution 
Avenue NW, Washington, DC 20551-0001, not later than February 12, 2024.
    A. Federal Reserve Bank of Chicago (Colette A. Fried, Assistant 
Vice President) 230 South LaSalle Street, Chicago, Illinois 60690-1414. 
Comments can also be sent electronically to 
<a href="/cdn-cgi/l/email-protection#51123e3c3c343f25227f3021213d38323025383e3f22113239387f3723337f3e2336"><span class="__cf_email__" data-cfemail="40032f2d2d252e34336e2130302c29232134292f2e33002328296e2632226e2f3227">[email protected]</span></a>:
    1. Castle Creek Capital Partners VI, LP, San Diego, California; to 
acquire voting shares of Tri-County Financial Group, Inc., and thereby 
indirectly acquire voting shares of First State Bank, both of Mendota, 
Illinois.

    Board of Governors of the Federal Reserve System.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2024-01602 Filed 1-25-24; 8:45 am]
BILLING CODE P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 17-41277

Conference Calendar

UNITED STATES OF AMERICA,

Plaintiff–Appellee,

v.

ARMANDO ZARCO-CONTRERAS, also known as Jose Luis Bravo-Lopez,

Defendant–Appellant.

Appeal from the United States District Court

for the Southern District of Texas

USDC No. 7:17-CR-1267-1

Before KING, ELROD, and WILLETT, Circuit Judges.

PER CURIAM:*

The Federal Public Defender appointed to represent Armando ZarcoContreras has moved for leave to withdraw and has filed a brief in accordance 

with Anders v. California, 386 U.S. 738 (1967), and United States v. Flores, 632 

F.3d 229 (5th Cir. 2011). Zarco-Contreras has not filed a response. We have 

reviewed counsel’s brief and the relevant portions of the record reflected 

 

* Pursuant to 5TH CIR. R. 47.5, the court has determined that this opinion should not 

be published and is not precedent except under the limited circumstances set forth in 5TH 

CIR. R. 47.5.4.

United States Court of Appeals

Fifth Circuit

FILED

August 8, 2018

Lyle W. Cayce

Clerk

 Case: 17-41277 Document: 00514590754 Page: 1 Date Filed: 08/08/2018
No. 17-41277

2

therein. We concur with counsel’s assessment that the appeal presents no 

nonfrivolous issue for appellate review.

Accordingly, counsel’s motion for leave to withdraw is GRANTED, 

counsel is excused from further responsibilities herein, and the APPEAL IS 

DISMISSED. See 5TH CIR. R. 42.2.

 Case: 17-41277 Document: 00514590754 Page: 2 Date Filed: 08/08/2018
II

104TH CONGRESS

2D SESSION S. 1781

To amend the Harmonized Tariff Schedule of the United States to provide

for duty free treatment for epoxide resins.

IN THE SENATE OF THE UNITED STATES

MAY 20, 1996

Mr. CRAIG introduced the following bill; which was read twice and referred

to the Committee on Finance

A BILL

To amend the Harmonized Tariff Schedule of the United

States to provide for duty free treatment for epoxide resins.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. ELIMINATION OF DUTY ON EPOXIDE RESINS.

4 (a) IN GENERAL.—Subheading 3907.30.00 of the

5 Harmonized Tariff Schedule of the United States is

6 amended to read as follows:

‘‘ 3907.30.00 Epoxide resins ................................. Free Free (A, CA,

E, IL, J, K,

MX)

15.4¢/kg +

47% ’’.

7 (b) EFFECTIVE DATE.—The amendment made by

8 subsection (a) applies with respect to goods entered, or
2

•S 1781 IS

1 withdrawn from warehouse for consumption, on or after

2 the 15th day after the date of the enactment of this Act.

Æ
**EXHIBIT 31.2**

 

**CERTIFICATIONS**

 

I, Thomas E. Morell, certify that: 

 

1. I have reviewed this annual report on Form 10-K of D&E Communications, Inc.; 

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a materialfact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly presentin all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as definedin Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and we have: 

 

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under oursupervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) evaluated the effectiveness of theregistrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(c) disclosed in this report any change inthe registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or isreasonably likely to materially affect, the registrant’s internal control over financial reporting; and 

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting,to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function): 

 

(a) all significant deficiencies in the design or operation of internal controls over financial reporting which are reasonably likely toadversely affect the registrant’s ability to record, process, summarize and report financial information; and 

 

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’sinternal control over financial reporting.
Exhibit 99.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY
ACT OF 2002

I hereby certify that the Quarterly Report of New England Acquisitions, Inc. on
Form 10-QSB for the quarterly period ended June 30, 2002, fully complies with
the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of
1934 and that information contained in the Quarterly Report fairly presents, in
all material respects, the financial condition of New England Acquisitions, Inc


Date:  August 15, 2002                   By: /s/ Gary Cella
                                                 ---------------
                                                 Gary Cella
                                                 Chief Executive Officer and
                                                 Cheif Financial Officer
<PAGE>


                                  EXHIBIT 31.1

                                 CERTIFICATIONS

I, Gary S. Jacob, certify that:

1) I have reviewed this quarterly report on Form 10-QSB of Callisto
Pharmaceuticals, Inc.

2) Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;

3) Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

4) The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

a) Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this quarterly report is being prepared;

b) Evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and

c) Disclosed in this report any change in the registrant's internal control over
financial reporting that occurred during the registrant's most recent fiscal
quarter (the registrant's fourth fiscal quarter in the case of an annual report)
that has materially affected, or is reasonably likely to materially affect, the
registrant's internal control over financial reporting; and

5) The registrant's other certifying officers and I have disclosed, based on our
most recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of the registrant's board of
directors (or persons performing the equivalent functions);

a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal control over
financial reporting.

Date: July 2, 2004


                                                       /s/ Gary S. Jacob
                                                       -----------------
                                                       Gary S. Jacob
                                                       Chief Executive Officer
**Exhibit 32.2**

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Theundersigned, the Chief Financial Officer of Gladstone Capital Corporation (the “Company”),hereby certifies on the date hereof, pursuant to 18 U.S.C. §1350(a), as adoptedpursuant to Section 906 of The Sarbanes-Oxley Act of 2002, that theQuarterly Report on Form 10-Q for the quarter ended December 31, 2007(“Form 10-Q”), filed concurrently herewith by the Company, fully complieswith the requirements of Section 13(a) or Section 15(d) ofthe Securities Exchange Act of 1934, as amended, and that the informationcontained in the Form 10-Q fairly presents, in all material respects, thefinancial condition and results of operations of the Company.

 

Dated:  February 5, 2008

 

 
| /s/ Harry Brill         |   |
|-------------------------|--------|
| Harry Brill             |   |
| Chief Financial Officer |   |
Order entered March 6 , 2015

In The 

## Court of Appeals Fifth District of Texas at Dallas

No. 05
- 14
- 01298
- CV TEXAS TRUE CHOICE, I NC., Appellant

V. BAYLOR HEALTH CARE S YSTEM, Appellee On Appeal from the 14th Judicial District Court

Dallas County, Texas Trial Court Cause No. DC
- 13
- 11409



### O RDER
We GRANT appellant’s March 3, 2015 unopposed second motion for an extension of time to file a brief. Appellant shall file a brief by APRIL 6, 2015 . We caution appellant that no further extension of time will be granted absent extraordinary circumstances.

/s/ ELIZABETH LANG

- MIERS JUSTICE
EXHIBIT32.1

 

CERTIFICATIONPURSUANT TO

18U.S.C. SECTION1350,

ASADOPTED PURSUANT TO

SECTION906 OF THE SARBANES-OXLEY ACT OF 2002

 

Inconnection with the Quarterly Report of Renovo Holdings (the"Company") on Form 10-QSB for the period ended June 30, 2004, as filedwith the Securities and Exchange Commission on the date hereof (the"Report"), I, Stephen W. Carnes, President and Chief Executive Officer ofthe Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant toSection 906 of the Sarbanes-Oxley Act of 2002, that:

-  The    Report fully complies with the requirements of Section 13(a) or 15(d) of the    Securities Exchange Act of 1934; andThe    information contained in the Report fairly presents, in all material    respects, the financial condition and results of operations of the Company.
 

/S/StephenW. Carnes                               

StephenW. Carnes

Presidentand Chief Executive Officer

August24, 2004